New device automates fluid removal in heart failure – could it be a game changer?
Disease control
Completed
This study tested a bedside device called the Reprieve Decongestion Management System in 100 hospitalized patients with acute decompensated heart failure. The device automatically adjusts the dose of a diuretic (furosemide) and saline based on the patient's real-time urine output…
Phase: NA • Sponsor: Reprieve Cardiovascular, Inc • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC